Some exciting news just in! Rocket Pharma has disclosed exciting information about their gene therapy trial for patients with LAD-1 deficiency. Please read the summary, which describes the clinical trial, the disease, and the six month data showing the therapy was well tolerated and induced a restoration of CD18 levels.